NIAGEN BIOSCIENCE, INC. Convertible Notes Payable, Current
NIAGEN BIOSCIENCE, INC. (NAGE) had Convertible Notes Payable, Current of $9.99 million as of 2019-06-30, per its 10-Q filed 2019-08-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2019-08-07
- 2019-06-30: Convertible Notes Payable, Current $9.99M.
- 2018-12-31: Convertible Notes Payable, Current $0.00.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2019-06-30 | $9.99M 10-Q · filed 2019-08-07 |
| 2018-12-31 | $0.00 10-Q · filed 2019-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |